ETON Stock Summary and Trading Ideas (Eton Pharmaceuticals | NASDAQ:ETON)

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Eton Pharmaceuticals trades on the NASDAQ stock market under the symbol ETON.

As of September 17, 2026, ETON stock price climbed to $57.07 with 290,384 million shares trading.

ETON has a beta of -0.65, meaning it tends to be less sensitive to market movements. ETON has a correlation of 0.02 to the broad based SPY ETF.

ETON has a market cap of $1.63 billion. This is considered a Small Cap stock.

Last quarter Eton Pharmaceuticals reported $38 million in Revenue and $.43 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.25.

In the last 3 years, ETON traded as high as $66.37 and as low as $3.03.

The top ETF exchange traded funds that ETON belongs to (by Net Assets): VTI, IWM, VXF, IWO, XPH.

ETON has outperformed the market in the last year with a return of +222.8%, while the SPY ETF gained +16.8%. In the last 3 month period, ETON beat the market returning +74.2%, while SPY returned +3.4%. However, in the most recent 2 weeks ETON has underperformed the stock market by returning -4.7%, while SPY returned -1.4%.

ETON support price is $54.61 and resistance is $58.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ETON shares will trade within this expected range on the day.